LTGO analyst estimates
Latigo Biotherapeutics (LTGO) analyst ratings, the average price target and its range, and every firm's latest call.
- 0 firms rate LTGO: 0 buy, 0 hold, 0 sell.
- The average price target is $52.25 from None analysts, from $36.00 to $73.00.
Updated 2026-11-11 00:47 UTC